Continuous subcutaneous infusion delivery of apomorphine in Parkinson's disease: a systematic review

PL Kukkle, D Garg, M Merello - Movement disorders clinical …, 2023 - Wiley Online Library
Background Continuous subcutaneous apomorphine infusion (CSAI) is one of the advanced
therapies for Parkinson's disease (PD). Methods A systematic review of all published articles …

Influence of continuous subcutaneous apomorphine infusion on cognition and behavior in Parkinson's disease: A systematic review

JF Houvenaghel, M Meyer, E Schmitt, A Arifi… - Revue …, 2024 - Elsevier
Introduction The efficacy of continuous subcutaneous apomorphine infusion (CSAI) for motor
complications of Parkinson's disease (PD) is established. However, its effect on cognition …

Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality …

JF Houvenaghel, S Drapier, J Duprez… - Journal of the …, 2018 - Elsevier
Introduction: Treatment optimization using continuous subcutaneous apomorphine infusion
(CSAI) improves the control of motor fluctuations of patients with Parkinson's disease (PD) …